Skip to main content

Table 1 Clinicopathological characteristics of the patients

From: Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients

Clinicopathological characteristics

No (%)

All patients

104 (100.0)

Age in years (21–79)

 mean: 56.5 ± 15.4; median: 58.5

 

Gender

 Female

60 (57.7)

 Male

44 (42.3)

Primary tumor location

 Head/neck

15 (14.4)

 Upper extremity

18 (17.3)

 Lower extremity

25 (24.0)

 Trunk

42 (40.4)

 Hand/foot

4 (3.8)

Primary tumor (pT)

 pT1

34 (32.7)

 pT2

20 (19.2)

 pT3

27 (26.0)

 pT4

23 (22.1)

Sentinel lymph node biopsy status (SNLB)

60 (57.7)

 No metastases (SNLB-)

48 (80.0)

 Metastases present (SNLB+)

12 (20.0)

Regional lymph nodes status (pN)

 

 No metastases (pN-)

86 (82.7)

 Metastases present (pN+)

18 (17.3)

Recurrence

 No

87 (83.7)

 Yes

17 (16.3)

Distant metastases

 No

99 (95.2)

 Yes

5 (4.8)